These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9259370)
1. APOE is linked to Alzheimer's disease in a large pedigree. Cai X; Fallin D; Stanton J; Scibelli P; Duara R; Crawford F; Mullan M Am J Med Genet; 1997 Jul; 74(4):365-9. PubMed ID: 9259370 [TBL] [Abstract][Full Text] [Related]
2. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. Bennett C; Crawford F; Osborne A; Diaz P; Hoyne J; Lopez R; Roques P; Duara R; Rossor M; Mullan M Am J Med Genet; 1995 Feb; 60(1):1-6. PubMed ID: 7485228 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
4. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. Liu L; Forsell C; Lilius L; Axelman K; Corder EH; Lannfelt L Am J Med Genet; 1996 May; 67(3):306-11. PubMed ID: 8725748 [TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010 [TBL] [Abstract][Full Text] [Related]
7. Genome scan on Swedish Alzheimer's disease families. Sillén A; Forsell C; Lilius L; Axelman K; Björk BF; Onkamo P; Kere J; Winblad B; Graff C Mol Psychiatry; 2006 Feb; 11(2):182-6. PubMed ID: 16288313 [TBL] [Abstract][Full Text] [Related]
8. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC; Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497 [TBL] [Abstract][Full Text] [Related]
11. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623 [TBL] [Abstract][Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
13. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]